Lipocine (LPCN) Interest & Investment Income (2017 - 2025)
Lipocine (LPCN) posted Interest & Investment Income of $174,208 for Q3 2025, down 36.3% from $273,574 a year earlier and down 12.3% from the prior quarter.
Powered by 
Analysis
Lipocine (LPCN) Interest & Investment Income (2017 - 2025) Analysis & Trends
For the trailing twelve months through Sep 30, 2025, Interest & Investment Income at Lipocine was $831,474, down 31.5% year-over-year; for FY2024, it came in at $1.15 million, down 16.1% from FY2023.
- Annual Interest & Investment Income shows a five-year compound annual growth rate of 22.0% (FY2019 to FY2024).
- In prior years, Lipocine's Interest & Investment Income was $1.37 million in FY2023 (+138.7%), $572,578 in FY2022 (+745.8%), $67,700 in FY2021 (-10.5%) and $75,650 in FY2020 (-82.1%).
- The Q3 2025 figure stands as the lowest quarterly Interest & Investment Income since Q3 2022.
- On a year-over-year basis, Interest & Investment Income has declined in each of the last seven quarters, with an average decline of 21.0% over the last eight quarters.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q3 2022, with growth of 849.8%; the weakest was Q4 2020, with a decline of 96.1%.
- According to Business Quant data, Interest & Investment Income for the three prior quarters was $198,637 (Q2 2025), $225,511 (Q1 2025) and $233,118 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Lipocine | 11.11 Mn | -56.60 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 174,208.00 |
| Jun 30, 2025 | 198,637.00 |
| Mar 31, 2025 | 225,511.00 |
| Dec 31, 2024 | 233,118.00 |
| Sep 30, 2024 | 273,574.00 |
| Jun 30, 2024 | 308,845.00 |
| Mar 31, 2024 | 331,364.00 |
| Dec 31, 2023 | 299,379.00 |
| Sep 30, 2023 | 317,569.00 |
| Jun 30, 2023 | 379,521.00 |
| Mar 31, 2023 | 370,469.00 |
| Dec 31, 2022 | 297,158.00 |
| Sep 30, 2022 | 163,966.00 |
| Jun 30, 2022 | 69,877.00 |
| Mar 31, 2022 | 41,576.00 |
| Dec 31, 2021 | 22,443.00 |
| Sep 30, 2021 | 17,264.00 |
| Jun 30, 2021 | 17,344.00 |
| Mar 31, 2021 | 10,649.00 |
| Dec 31, 2020 | 2,921.00 |
API Access
Lipocine Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();